Antifungal therapeutic options and challenges - Vienna 2024

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

International Congresses Vienna 2024 Antifungal therapeutic options and challenges

Respiratory infections

Chair(s): Daiana Stolz, Hitasha Rupani, Thomas Wilkinson

Session type: State of the art session

Antifungal therapeutic options and challenges

Martin Hoenigl

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

The spectrum of pulmonary aspergillosis

Eva Van Braeckel

Replay

Slides

Microbiological diagnosis of pulmonary aspergillosis

Paul Verveij

Replay

Slides

Antifungal therapeutic options and challenges

Martin Hoenigl

Replay

Slides

Chronic pulmonary aspergillosis in people with post-tuberculosis lung disease or cystic fibrosis

Helmut Salzer

Replay

Slides

Discussion and Q&A

Replay

Session aims

To describe the spectrum of pulmonary aspergillosis; to explain the microbiological diagnosis and interpretation of drug sensitivity test results of pulmonary aspergillus infections; to describe the antifungal therapeutic options and challenges for pulmonary aspergillus.

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}